Tapewire

Nasdaq · USD

CORT

CORCEPT THERAPEUTICS INC

Export transactions ↓
Tapewire entity
2620
SEC CIK
0001088856
Parsed reports
567

Last 12 months

Inside the activity.

2 purchase rows · 107 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202505
Jan 202601
Feb 202601
Mar 202623
Apr 202601
May 202605
Jun 2026012
Jul 2026026
Aug 2026018
Sep 2026015
Oct 202609

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 13, 2020 Filed Jul 15, 2020 21:46 UTC
Hunt HazelChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $15.82 $0.00
Disclosure

SEC source: 0000899243-20-019201 · doc4.xml · derivative · entry 1

Hunt Hazel · CIK 0001698307 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-07-13

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of July 1, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on July 1, 2024.

Read SEC document
July 13, 2020 Filed Jul 15, 2020 21:39 UTC
Lyon Joseph DouglasChief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $15.82 $0.00
Disclosure

SEC source: 0000899243-20-019199 · doc4.xml · derivative · entry 1

Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-07-13

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of July 1, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on July 1, 2024.

Read SEC document
July 10, 2020 Filed Jul 17, 2020 22:17 UTC GiftCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-019563 · doc4.xml · nonDerivative · entry 1

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust

Disclosed balance after: 1,319,074

F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Read SEC document
May 28, 2020 Filed May 29, 2020 20:09 UTC Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $3.47 $0.00
Disclosure

SEC source: 0001225208-20-008345 · doc4.xml · derivative · entry 6

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2020-06-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Exercisable date is 6/23/2010

F1 · ownership.direct: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.

Read SEC document
May 28, 2020 Filed May 29, 2020 20:09 UTC SaleCommon Stock 30,000 $15.70 $471,060.00
Disclosure

SEC source: 0001225208-20-008345 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 996,838

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.69 to $15.7602, inclusive. The reporting person undertakes to provide to Corcept Therapeutics Incorporated, and any security holder of Corcept Therapeutics Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · ownership.direct: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.

Read SEC document
May 28, 2020 Filed May 29, 2020 20:09 UTC Exercise / conversionCommon Stock 30,000 $3.47 $104,100.00
Disclosure

SEC source: 0001225208-20-008345 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,026,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.

Read SEC document
May 27, 2020 Filed May 29, 2020 23:23 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0000899243-20-014630 · doc4.xml · derivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-05-26

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over a one-year period.

Read SEC document
May 27, 2020 Filed May 29, 2020 23:23 UTC GrantStock Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0000899243-20-014629 · doc4.xml · derivative · entry 1

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2030-05-26

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over a one-year period.

Read SEC document
May 27, 2020 Filed May 29, 2020 23:23 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0000899243-20-014628 · doc4.xml · derivative · entry 1

MAHONEY DAVID L · CIK 0001224091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-05-26

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over a one-year period.

Read SEC document
May 27, 2020 Filed May 29, 2020 23:22 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0000899243-20-014627 · doc4.xml · derivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-05-26

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over a one-year period.

Read SEC document
May 27, 2020 Filed May 29, 2020 23:19 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0000899243-20-014622 · doc4.xml · derivative · entry 1

Park Kimberly · CIK 0001788208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-05-26

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over a one-year period.

Read SEC document
May 27, 2020 Filed May 29, 2020 20:09 UTC GrantStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0001225208-20-008345 · doc4.xml · derivative · entry 5

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-05-27

F5 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over one-year period.

Read SEC document
May 22, 2020 Filed May 27, 2020 23:53 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $6.55 $0.00
Disclosure

SEC source: 0000899243-20-014352 · doc4.xml · derivative · entry 3

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2025-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.

F2 · derivative.exercise_date: Fully exercisable.

Read SEC document
May 22, 2020 Filed May 27, 2020 23:53 UTC SaleCommon Stock 5,000 $16.10 $80,500.00
Disclosure

SEC source: 0000899243-20-014352 · doc4.xml · nonDerivative · entry 2

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.

Read SEC document
May 22, 2020 Filed May 27, 2020 23:53 UTC Exercise / conversionCommon Stock 5,000 $6.55 $32,750.00
Disclosure

SEC source: 0000899243-20-014352 · doc4.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.

Read SEC document
May 22, 2020 Filed May 27, 2020 23:48 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 38,984 $0.00 Strike: $3.47 $0.00
Disclosure

SEC source: 0000899243-20-014349 · doc4.xml · derivative · entry 3

MAHONEY DAVID L · CIK 0001224091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,984 shares

Expires 2020-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the number of shares issued upon net-exercise of stock option.

F2 · derivative.exercise_date: Fully exercisable.

Read SEC document
May 22, 2020 Filed May 27, 2020 23:48 UTC Exercise / conversionCommon Stock 38,984 $3.47 $135,274.48
Disclosure

SEC source: 0000899243-20-014349 · doc4.xml · nonDerivative · entry 1

MAHONEY DAVID L · CIK 0001224091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,984

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the number of shares issued upon net-exercise of stock option.

Read SEC document
March 12, 2020 Filed Mar 13, 2020 22:00 UTC GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $10.48 $0.00
Disclosure

SEC source: 0000899243-20-008294 · doc4.xml · derivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2030-03-12

F1 · derivative.exercise_date: Shares subject to the stock option vest and become exercisable with respect to 25% of the shares on the first anniversary of the date of grant and, thereafter, at the rate of 2.08334% of the total number of shares per month, until fully vested and exercisable on the fourth anniversary of the date of grant, subject to the Reporting Person's continued service.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 23:54 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
Disposition to issuerCommon Stock 20,338 $13.54 $275,376.52
Disclosure

SEC source: 0000899243-20-006342 · doc4.xml · nonDerivative · entry 1

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,499,214

F1 · kind: These shares were sold so the Reporting Person could satisfy his remaining tax liability arising from a net (cashless) exercise of stock options that occurred in 2019. The date of the net exercise was March 20, 2019. The options subject to the net exercise were to expire on March 26, 2019.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:14 UTC
Robb Gary CharlesChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $13.56 $0.00
Disclosure

SEC source: 0000899243-20-004048 · doc4.xml · derivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2030-02-06

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2024.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:13 UTC
Maduck SeanSee Remarks
GrantStock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $13.56 $0.00
Disclosure

SEC source: 0000899243-20-004046 · doc4.xml · derivative · entry 1

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2030-02-06

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2024.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:13 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $13.56 $0.00
Disclosure

SEC source: 0000899243-20-004044 · doc4.xml · derivative · entry 1

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2030-02-06

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2024.

Read SEC document
February 07, 2020 Filed Feb 11, 2020 22:09 UTC
Grauer AndreasChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $13.56 $0.00
Disclosure

SEC source: 0000899243-20-004040 · doc4.xml · derivative · entry 1

Grauer Andreas · CIK 0001770511 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2030-02-06

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2024.

Read SEC document
January 01, 2020 Filed Feb 3, 2021 22:39 UTC GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-001608 · doc5.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,114,793

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F1 · price: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
December 17, 2019 Filed Feb 12, 2020 22:17 UTC
Robb Gary CharlesChief Financial Officer
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-004320 · doc5.xml · nonDerivative · entry 3

Robb Gary Charles · CIK 0001529655 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Custodial account for child

Disclosed balance after: 3,735

F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

Read SEC document
December 17, 2019 Filed Feb 12, 2020 22:17 UTC
Robb Gary CharlesChief Financial Officer
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-004320 · doc5.xml · nonDerivative · entry 2

Robb Gary Charles · CIK 0001529655 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Custodial account for child

Disclosed balance after: 3,735

F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

Read SEC document
December 17, 2019 Filed Feb 12, 2020 22:17 UTC
Robb Gary CharlesChief Financial Officer
GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-004320 · doc5.xml · nonDerivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Custodial account for child

Disclosed balance after: 3,735

F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

Read SEC document
December 09, 2019 Filed Dec 11, 2019 21:42 UTC
Robb Gary CharlesChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0000899243-19-028931 · doc4.xml · derivative · entry 6

Robb Gary Charles · CIK 0001529655 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 30,000 shares

Expires 2023-11-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

Read SEC document
December 09, 2019 Filed Dec 11, 2019 21:42 UTC
Robb Gary CharlesChief Financial Officer
SaleCommon Stock 30,000 $13.73 $412,029.00
Disclosure

SEC source: 0000899243-19-028931 · doc4.xml · nonDerivative · entry 2

Robb Gary Charles · CIK 0001529655 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,025

F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $13.71 to $13.79 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Read SEC document
December 09, 2019 Filed Dec 11, 2019 21:42 UTC
Robb Gary CharlesChief Financial Officer
Exercise / conversionCommon Stock 30,000 $1.92 $57,600.00
Disclosure

SEC source: 0000899243-19-028931 · doc4.xml · nonDerivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 28, 2019 Filed Oct 30, 2019 21:36 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 284,218 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0000899243-19-026357 · doc4.xml · derivative · entry 5

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 284,218 shares

Expires 2019-12-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

Read SEC document
October 28, 2019 Filed Oct 30, 2019 21:36 UTC Tax withholdingCommon Stock 153,754 $14.63 $2,249,421.02
Disclosure

SEC source: 0000899243-19-026357 · doc4.xml · nonDerivative · entry 2

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,246

F1 · kind: The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares.

Read SEC document
October 28, 2019 Filed Oct 30, 2019 21:36 UTC Exercise / conversionCommon Stock 284,218 $2.30 $653,701.40
Disclosure

SEC source: 0000899243-19-026357 · doc4.xml · nonDerivative · entry 1

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 28, 2019 Filed Jul 17, 2020 22:16 UTC Amendment Exercise / conversionStock Option (Right to Buy) · Derivative 284,218 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0000899243-20-019562 · doc4a.xml · derivative · entry 5

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 284,218 shares

Expires 2019-12-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully exercisable.

Read SEC document
October 28, 2019 Filed Jul 17, 2020 22:16 UTC Amendment Tax withholdingCommon Stock 153,712 $14.63 $2,248,806.56
Disclosure

SEC source: 0000899243-20-019562 · doc4a.xml · nonDerivative · entry 2

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,288

F1 · kind: The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares.

F2 · balance_after: Reflects the adjusted number of shares following the return of 42 shares withheld in excess of the number of shares initially withheld as payment for taxes in connection with the cashless stock option exercise.

Read SEC document
October 28, 2019 Filed Jul 17, 2020 22:16 UTC Amendment Exercise / conversionCommon Stock 284,218 $2.30 $653,701.40
Disclosure

SEC source: 0000899243-20-019562 · doc4a.xml · nonDerivative · entry 1

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2019 Filed Sep 18, 2019 21:24 UTC GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $13.49 $0.00
Disclosure

SEC source: 0000899243-19-023845 · doc4.xml · derivative · entry 1

Park Kimberly · CIK 0001788208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2029-09-17

F1 · derivative.exercise_date: Shares subject to the stock option vest and become exercisable with respect to 25% of the shares on the first anniversary of the date of grant and, thereafter, at the rate of 2.08334% of the total number of shares per month, until fully vested and exercisable on the fourth anniversary of the date of grant, subject to the Reporting Person's continued service.

Read SEC document
June 18, 2019 Filed Jun 19, 2019 23:19 UTC GrantStock Option (Right To Buy) · Derivative 25,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001225208-19-009444 · doc4.xml · derivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2019-06-18

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over one-year period.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:08 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0000899243-19-017627 · doc4.xml · derivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2029-06-18

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over a one-year period.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:07 UTC GrantStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0000899243-19-017626 · doc4.xml · derivative · entry 1

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2029-06-18

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over a one-year period.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:06 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0000899243-19-017625 · doc4.xml · derivative · entry 1

MAHONEY DAVID L · CIK 0001224091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2029-06-18

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over a one-year period.

Read SEC document
June 03, 2019 Filed Jun 4, 2019 21:04 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0000899243-19-015487 · doc4.xml · derivative · entry 3

MAHONEY DAVID L · CIK 0001224091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2019-06-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully exercisable

Read SEC document
June 03, 2019 Filed Jun 4, 2019 21:04 UTC Exercise / conversionCommon Stock 50,000 $0.96 $48,000.00
Disclosure

SEC source: 0000899243-19-015487 · doc4.xml · nonDerivative · entry 1

MAHONEY DAVID L · CIK 0001224091 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:24 UTC Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001225208-19-008891 · doc4.xml · derivative · entry 5

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2019-06-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:24 UTC SaleCommon Stock 30,000 $9.78 $293,298.00
Disclosure

SEC source: 0001225208-19-008891 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 996,838

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $9.75 to $9.80, inclusive. The reporting person undertakes to provide to Corcept Therapeutics Incorporated, and any security holder of Corcept Therapeutics Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · ownership.direct: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:24 UTC Exercise / conversionCommon Stock 30,000 $0.96 $28,800.00
Disclosure

SEC source: 0001225208-19-008891 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,026,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.

Read SEC document
April 01, 2019 Filed Apr 2, 2019 17:36 UTC
Grauer AndreasChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 425,000 $0.00 Strike: $11.29 $0.00
Disclosure

SEC source: 0000899243-19-009521 · doc4.xml · derivative · entry 1

Grauer Andreas · CIK 0001770511 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 425,000

Underlying: Common Stock · 425,000 shares

Expires 2029-03-31

F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 25% of the total number of shares on the one-year anniversary of March 18, 2019 and 1/36th of the remaining number of shares on each monthly anniversary thereafter, so that the total number of shares subject to this option becomes fully vested and exercisable on March 18, 2023.

Read SEC document
March 20, 2019 Filed Mar 21, 2019 19:01 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 782,885 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0000899243-19-008664 · doc4.xml · derivative · entry 3

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 782,885 shares

Expires 2019-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully exercisable.

Read SEC document
March 20, 2019 Filed Mar 21, 2019 19:01 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
Tax withholdingCommon Stock 427,528 $11.93 $5,100,409.04
Disclosure

SEC source: 0000899243-19-008664 · doc4.xml · nonDerivative · entry 2

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,519,552

F1 · kind: The shares were withheld at the election of the Reporting Person as payment for the purchased shares and to satisfy tax withholding obligations in connection with the purchase of the shares.

Read SEC document
March 20, 2019 Filed Mar 21, 2019 19:01 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
Exercise / conversionCommon Stock 782,885 $1.19 $931,633.15
Disclosure

SEC source: 0000899243-19-008664 · doc4.xml · nonDerivative · entry 1

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,947,080

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.